Missed Opportunities for Human Immunodeficiency Virus and Syphilis Testing Among Men Who Have Sex With Men in China: A Cross-Sectional Study.
Missed Opportunities for Human Immunodeficiency Virus and Syphilis Testing Among Men Who Have Sex With Men in China: A Cross-Sectional Study.
复制标题
DOI:
10.1097/olq.0000000000000773
复制
发表时间:
2018-06
影响因子:
3.1
通讯作者:
Tucker JD
中科院分区:
文献类型:
--
作者:
Ong JJ;Fu H;Pan S;Smith MK;Wu D;Wei C;Cao B;Ma W;Yang L;Tang W;Tucker JD
Men who have sex with men(MSM) are at high risk of HIV/syphilis. To inform strategies for dual testing, we describe patterns of HIV/syphilis testing, and examine factors associated with never testing for HIV/syphilis in China. An online survey(2016) was completed by MSM from eight cities: men born biologically male, age ≥16 years, and had sex with another man at least once during their lifetime. Demographic, sexual behavioural and HIV/syphilis testing data were collected. Multivariable multinomial logistic regression identified characteristics associated with men who never tested for HIV/syphilis, compared to men who ever tested for both infections. Overall, 2,105 men participated. Among them, 35.1%(738/2105) never tested for HIV/syphilis, and in those ever tested for HIV, only half (54.0%,709/1312) had tested for syphilis. Relative to men who had ever tested for both infections, those with increased probability of never testing for HIV/syphilis include non-gay sexual identity (prevalence odds ratio(POR) 1.86, 95%CI[1.45–2.37]), not disclosed their sexuality/sexual history with men other than their regular partner (POR 2.22, [1.75–2.78]) or with health professionals (POR 11.11, [7.69–14.29]), no condomless sex with casual partners in the last three months (POR 1.89, [1.37–2.56]), no community engagement in sexual health (POR 15.16, [9.40–24.45]), and mainly met partners offline (POR 1.49, [1.16–1.92]). There are significant gaps in lifetime testing for HIV/syphilis amongst Chinese MSM. Strategies to target never testers and integrate syphilis testing within HIV testing services are urgently needed. Future opportunities include point-of-care dual test kits, and testing in China’s expanding primary healthcare system.